Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,981-1,992 of 4,306
Drug study icon
CompletedNCT00249132

Effectiveness of effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in schizophrenia

This study is completed. It is testing effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Sponsor
Janssen, LP
Condition
Schizophrenia
Drug study icon
CompletedNCT00246285

Effectiveness of effectiveness and Safety of Risperidone in schizophrenia

This study is completed. It is testing effectiveness and Safety of Risperidone for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 17 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedNCT00111189

Effectiveness of efficacy (Effectiveness) of Paliperidone Palmitate in schizophrenia

This study is completed in the United States, in Costa Rica, in Mexico, .... It is testing efficacy (Effectiveness) of Paliperidone Palmitate for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Costa Rica, Mexico, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedNCT00210769

Effectiveness of Extended-release Oral Paliperidone in schizophrenia

This study is completed. It is testing Extended-release Oral Paliperidone for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedNCT01926912

Usage of Paliperidone Palmitate in people with Schizophrenia in a Hospital Setting

This study is completed in Belgium, in Bulgaria, in Denmark, .... It is testing usage of Paliperidone Palmitate for schizophrenia.

Multiple locations, including Diest
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Belgium, Bulgaria, Denmark, ...
Sponsor
Janssen-Cilag International NV
Condition
Schizophrenia
Drug study icon
CompletedNCT03697252

Safety study of Safety and Efficacy of KarXT in schizophrenia

This study is completed in the United States. It is testing Safety and Efficacy of KarXT for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
CompletedNCT00034775

Safety study of Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in schizophrenia

This study is completed. It is testing Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedNCT01559272

Safety study of pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in schizophrenia

This study is completed in the United States, in Belgium, in Bulgaria, .... It is testing pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Belgium, Bulgaria, ...
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.